Blog Layout
3C Secures Medicinal Cannabis Cultivation and Manufacturing License in Denmark
3C engaged with Cantiva ApS to create and submit an application for one of the first 11 medicinal cannabis cultivation and extraction/manufacturing licenses in Denmark. The country’s medicinal cannabis pilot program allows for the distribution of cannabis medicines through its existing medical system.
From the time of engagement with Cantiva ApS, we faced an extremely tight application timeline. Over a few weeks, we developed a comprehensive application covering quality assurance practices, facility designs, cultivation & processing equipment, Good Manufacturing Practices (GMP), Good Agricultural and Collection Practices (GACP), documentation practices, cultivation & processing plans, pharmaceutical manufacturing, and much more. The completed application contained over 2,000 pages of content. 3C’s guidance and articulation were integral in completing and submitting the application on time. Cantiva ApS’s application was successful, and the company was granted an authorization to cultivate and produce cannabis for medicinal use.
“…I had NEVER seen such a great team, working so hard to succeed at an application. I am, and will forever be impressed by you, and how fast and professional your approach was on these applications,” said Lars Nielsen, CEO of Cantiva ApS Denmark.
Share
Recommended Articles
This guide highlights all 3C Consulting has learned on helping clients to develop, licence, and grow legal cannabis businesses globally.
Lack of compliance for companies makes investment due diligence risky. This cannabis due diligence checklist supports success for your business.
Despite challenges, the cannabis industry is still growing stronger than ever. Learn how to secure limited cannabis business licenses amid COVID-19 hardships.
